(Q46050924)

English

European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update (English)

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

1 reference

based on heuristic

inferred from title

stem cell transplantation

1 reference

based on heuristic

inferred from title

Raoul Herbrecht

object named as

R Herbrecht

3

0 references

author name string

J Maertens

1

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

O Marchetti

2

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

O A Cornely

4

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

U Flückiger

5

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

P Frêre

6

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

B Gachot

7

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

W J Heinz

8

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

C Lass-Flörl

9

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

P Ribaud

10

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

A Thiebaut

11

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

C Cordonnier

12

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

Third European Conference on Infections in Leukemia

13

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

language of work or name

0 references

publication date

26 July 2010

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

Bone Marrow Transplantation

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

46

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

709-718

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

5

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

https://scigraph.springernature.com/pub.10.1038/bmt.2010.175

0 references

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of th

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Efficacy and safety of micafungin, an echinocandin antifungal agent, on invasive fungal infections in patients with hematological disorders

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Efficacy and safety of intravenous itraconazole as empirical antifungal therapy for persistent fever in neutropenic patients with hematological malignancies in Japan

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Empirical antifungal therapy in selected patients with persistent febrile neutropenia.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Clinically driven diagnostic antifungal approach in neutropenic patients: a prospective feasibility study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Comparison of caspofungin and amphotericin B for invasive candidiasis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Anidulafungin versus fluconazole for invasive candidiasis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Primary antifungal prophylaxis in leukaemia patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of invasive Candida and invasive Aspergillus infections in adult haematological patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

7 January 2021

based on heuristic

inferred from DOI database lookup

Guide to development of practice guidelines

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

7 January 2021

based on heuristic

inferred from DOI database lookup

Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/BMT.2010.175

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46050924&oldid=2089568071"